Skip to main content
SpringerLink
Log in

Ecopharmacovigilance

  • Chapter
  • First Online:
Pharmacovigilance

Abstract

“Our home – Earth – is in danger. What is at risk of being destroyed is not the planet itself, but the conditions that have made it hospitable for human beings” [1]. Al Gore, Nobel Peace Prize for his efforts to increase public awareness of the seriousness of the environmental situation, wrote this in 2007. Chemical substances, including pharmaceuticals, could contribute to the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Bibliography

  1. Gore A (2007) Moving beyond Kyoto. The New York Times, 1 July 2007, p 413. Available at: http://www.nytimes.com/2007/07/01/opinion/01gore.html. Accessed 31 Oct 2015

  2. Time to get clean (2015) Nature 526:164. Available at: http://www.nature.com/news/time-to-get-clean-1.18521. Accessed 31 Oct 2015

  3. Kummerer K, Velo GP (2006) Ecopharmacology: a New topic of importance in ecopharmacovigilance. Drug Saf 29(5):371–373

    Article  PubMed  Google Scholar 

  4. Velo GP, Moretti U (2010) Ecopharmacovigilance for better health. Drug Saf 33(11):963–968

    Article  PubMed  Google Scholar 

  5. Wise R (2002) Antimicrobial resistance: priorities for action. Antimicrob Chemother 49:585–586

    Article  CAS  Google Scholar 

  6. Direction Générale de la Santé (France). Plan National sur les Rèsidus de Medicaments dansl’Eau (PNRM), 2011 May 30. Available at: http://www.sante.gouv.fr/plan-national-sur-les-residus-de-medicaments-dans-les-eaux-pnrm-2010-2015.html. Accessed 31 Oct 2015

  7. Kummerer K, Velo GP (2006) Workshop “Ecopharmacology” Verona

    Google Scholar 

  8. “Progetto Ecofarmaco” – Verona 2012. Results available at: http://www.farmacieverona.it/dettaglio_info.asp?Tipo=1&VoceT=58&VoceD=301&PercorsoBack=Tipo%3D1%26Voce%3D58. Accessed 31 Oct 2015

  9. Tong AYC, Peake BM, Braund R (2011) Disposal practices for unused medications around the world. Environ Int. 37:292–298

    Google Scholar 

  10. Carlsson G, Örn S, Larsson DGJ (2009) Effluent from bulk drug production is toxic to aquatic vertebrates. Environ Toxicol Chem 28:2656–2662

    Article  CAS  PubMed  Google Scholar 

  11. Gunnarsson L, Kristiansson E, Rutgersson C et al (2009) Pharmaceutical industry effluent diluted 1:500 affects global gene expression, cytochrome P450 1A activity, and plasma phosphate in fish. Environ Toxicol Chem 28:2639–2647

    Article  CAS  PubMed  Google Scholar 

  12. Larsson DG, de Pedro C, Paxeus N (2007) Effluent from drug manufactures contains extremely high levels of pharmaceuticals. J Hazard Mater 30:751–755

    Article  Google Scholar 

  13. Fick J, Soderstrom H, Lindberg R, Phan C, Tysklind M et al (2009) Contamination of surface, ground, and drinking water from pharmaceutical production. Environ Toxicol Chem 28:2522–2527

    Article  CAS  PubMed  Google Scholar 

  14. British Environment Agency, 2004 Report

    Google Scholar 

  15. Zuccato E, Chiabrando C, Castiglioni S et al (2005) Cocaine in surface waters: a new evidence-based tool to monitor community drug abuse. Environ Health 4:14–20

    Article  PubMed  PubMed Central  Google Scholar 

  16. Heberer T (2002) Occurrence, fate, and removal of pharmaceuticals residues in the aquatic environment: a review of recent research data. Toxicol Lett 131:5–17

    Article  CAS  PubMed  Google Scholar 

  17. Kummerer K (2008) Pharmaceuticals in the environment: sources, fate, effects and risks. Springer-Verlag Berlin Heidelberg

    Google Scholar 

  18. Modified from Jones OA, Lester JN, Voulvoulis N (2005) Pharmaceuticals: a threat to drinking water? Trends Biotechnol 23(4):163–167

    Google Scholar 

  19. Communication from the Commission on the precautionary principle, point 3; 2nd February 2000. Available at: http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:52000DC0001. Accessed 31st Oct 2015

  20. Velo GP (2007) Why ecopharmacovigilance. Drug Saf 30(10):947

    Google Scholar 

  21. Edwards IR, Hugman B, Lindquist M, Velo GP et al (2010) Erice statement 2009: communication, medicines and patient safety. Br J Clin Pharmacol 69(2):207–208

    Article  Google Scholar 

  22. Watts G (2011) Something in the water. BMJ 343:d7236

    Article  PubMed  Google Scholar 

  23. Pharmas Project – ecological and human health risk assessments of antibiotics and anti-cancer drugs found in the environment. Available at: http://www.pharmas-eu.net. Accessed 31 Oct 2015

  24. Hazardous substances in Europe’s fresh and marine waters – an overview (2011) European Environment Agency Technical report 8

    Google Scholar 

  25. Knudsen FR, Schou AE, Wiborg ML et al (1997) Increase of plasma vitellogenin concentration in rainbow trout (Oncorhynchus mykiss) exposed to effluents from oil refinery treatment works and municipal sewage. Bull Environ Contam Toxicol 59:802–806

    Article  CAS  PubMed  Google Scholar 

  26. Richman C, Castensson S (2008) Impact of waste pharmaceuticals: an environmental hazard or “greenwash”? Pharm J 280:335–342

    Google Scholar 

  27. Liney KE, Jobling S, Shears JA et al (2005) Assessing the sensitivity of different life stages for sexual disruption in roach (Rutilus rutilus) exposed to effluents from wastewater treatment works. Environ Health Perspect 113(10):1299–1307

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Kidd KA, Blanchfield PJ, Mills KH et al (2007) Collapse of a fish population after exposure to a synthetic estrogen. Proc Natl Acad Sci U S A 104(21):8897–8901

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Guillette LJ Jr, Pickford DB, Crain DA et al (1996) Reduction in penis size and plasma testosterone concentrations in juvenile alligators living in a contaminated environment. Gen Comp Endocrinol 101:32–42

    Article  CAS  PubMed  Google Scholar 

  30. Oaks JL, Gilbert M, Virani MZ et al (2004) Diclofenac residues as the cause of vulture population decline in Pakistan. Nature 427:630–633

    Article  CAS  PubMed  Google Scholar 

  31. Schwaiger J, Ferling H, Mallow U, Wintermayr H, Negele RD (2004) Toxic effects of the non-steroidal anti-inflammatory drug diclofenac: Part I: histopathological alterations and bioaccumulation in rainbow trout. Aquat Toxicol 68(2):141–150

    Article  CAS  PubMed  Google Scholar 

  32. Carlsen E, Giwercman A, Keiding N et al (1992) Evidence for decreasing quality of semen during past 50 years. BMJ 305:609–613

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Sherins RJ (1995) Are semen quality and male fertility changing? N Engl J Med 332(5):327–328

    Article  CAS  PubMed  Google Scholar 

  34. Auger J, Kunstmann JM, Czyglik F et al (1995) Decline in semen quality among fertile men in Paris during the past 20 years. N Engl J Med 332:281–285

    Article  CAS  PubMed  Google Scholar 

  35. Margel D, Fleshner NE (2011) Oral contraceptive use is associated with prostate cancer: an ecological study. BMJ Open. Available at: http://bmjopen.bmj.com/content/1/2/e000311.full. Accessed 31 Oct 2015

  36. Correction to Margel and Fleshner (2012) BMJ Open 2. Available at: http://bmjopen.bmj.com/content/2/3/e000311corr1.full. Accessed 31 Oct 2015

  37. Kummerer K (2004) Resistance in the environment. J Antimicrob Chemother 54:311–320

    Article  CAS  PubMed  Google Scholar 

  38. Costa VM, McGrann KM, Hughes DW et al (2006) Sampling in the antibiotic resistome. Science 311:374–377

    Article  PubMed  Google Scholar 

  39. Midvedt T (2011) Penicillins, cephalosporins, other beta-lactam antibiotics, and tetracyclines. Meylers Side Effects Drugs Ann 33:491–508

    Article  Google Scholar 

  40. Commission Directive 97/6/EC of 30 January 1997 amending Council Directive 70/524/EEC concerning additives in feeding stuffs (1997) Off J Eur Comm L 35:11–13. Available at: http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:31997L0006. Accessed 31 Oct 2015

  41. Sørum M, Johnsen PJ, Aasnes B et al (2006) Prevalence, persistence, and molecular characterization of glycopeptide-resistant enterococci in Norwegian poultry and poultry farmers 3 to 8 years after the ban on avoparcin. Appl Environ Microbiol 72(1):516–521

    Article  PubMed  PubMed Central  Google Scholar 

  42. Verner-Jeffreys DW, Welch TJ, Schwarz T et al (2009) High prevalence of multidrug-tolerant bacteria and associated antimicrobial resistance genes isolated from ornamental fish and their carriage water. PLoS One 4(12):e8388. Available at: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008388

  43. Musto J, Kirk M, Lightfoot D et al (2006) Multi-drug resistant Salmonella Java infections acquired from tropical fish aquariums. Commun Dis Intell 30(2):222–227

    Google Scholar 

  44. Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use (2004) Off J Eur Commun n. L 136:34–57 Available at: http://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1446555019102&uri=CELEX:32004L0027. Accessed 31 Oct 2015

  45. Directive 2004/28/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/82/EC on the Community code relating to veterinary medicinal products (2004) Off J Eur Commun L 136:58–84. Available at:http://eur-lex.europa.eu/legal-content/it/TXT/?uri=CELEX:32004L0028. Accessed 31 Oct 2015

  46. Directive 2010/84/EU of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance, Directive 2001/83/EC on the Community code relating to medicinal products for human use (2010) Off J Eur Commun L 348:74–99. Available at: http://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1436776435438&uri=CELEX:32010L0084. Accessed 31 Oct 2015

  47. Directive 2013/39/EU of the European Parliament and of the Council of 12 August 2013 amending Directives 2000/60/EC and 2008/105/EC as regards priority substances in the field of water policy (2013) Off J Eur Commun L 226:1–17. Available at: http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex:32013L0039. Accessed 31 Oct 2015

Download references

Author information

Authors and Affiliations

  1. Department of Diagnostics and Public Health, Section of Pharmacology, University of Verona, P.le L. Scuro, 10, 37134, Verona, Italy

    Giampaolo Velo

Authors
  1. Giampaolo Velo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giampaolo Velo .

Editor information

Editors and Affiliations

  1. Uppsala Monitoring Centre, Uppsala, Sweden

    I. Ralph Edwards

  2. Uppsala Monitoring Centre, Uppsala, Sweden

    Marie Lindquist

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Velo, G. (2017). Ecopharmacovigilance. In: Edwards, I., Lindquist, M. (eds) Pharmacovigilance. Adis, Cham. https://doi.org/10.1007/978-3-319-40400-4_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-40400-4_18

  • Published:

  • Publisher Name: Adis, Cham

  • Print ISBN: 978-3-319-40399-1

  • Online ISBN: 978-3-319-40400-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation